Dentsply Sirona (NASDAQ: XRAY) insider transactions
In the twelve months to 10 November 2026, executives and directors of Dentsply Sirona reported 1 open-market sale of 82,200 shares ($915,708) and 11 open-market purchases of 136,083 shares ($1.6m), by 8 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 10 August 2026 | Fortson John C. | EVP & CFO | Grant or award | +24,014 | — | 24,014 | Form 4 |
| 7 August 2026 | Frohning Andrea L. | SVP, Chro | Shares withheld for tax | −802 | $12.12 | 63,191 | Form 4 |
| 15 June 2026 | Hosein Clyde | Director | Open-market purchase | +6,500 | $9.99 | 70,575 | Form 4 |
| 15 June 2026 | Gladden Brian T | Director | Open-market purchase | +9,985 | $10.02 | 61,849 | Form 4 |
| 12 June 2026 | Mazelsky Jonathan Jay | Director | Grant or award | +10,000 | $10.14 | 61,669 | Form 4 |
| 12 June 2026 | McKeon Brian P | Director | Open-market purchase | +10,000 | $10.12 | 10,000 | Form 4 |
| 11 June 2026 | Barber Michael J | Director | Open-market purchase | +15,175 | $9.89 | 55,943 | Form 4 |
| 11 June 2026 | Holden Betsy D | Director | Open-market purchase | +10,086 | $9.88 | 87,528 | Form 4 |
| 3 June 2026 | Barber Michael J | Director | Grant or award | +22,822 | — | 40,768 | Form 4 |
| 3 June 2026 | Forbes James D | Director | Grant or award | +28,887 | — | 38,887 | Form 4 |
| 3 June 2026 | Gladden Brian T | Director | Grant or award | +22,822 | — | 51,864 | Form 4 |
| 3 June 2026 | Holden Betsy D | Director | Grant or award | +22,822 | — | 77,442 | Form 4 |
| 3 June 2026 | Hosein Clyde | Director | Grant or award | +22,822 | — | 64,075 | Form 4 |
| 3 June 2026 | Mazelsky Jonathan Jay | Director | Grant or award | +22,822 | — | 51,669 | Form 4 |
| 3 June 2026 | McKeon Brian P | Director | Grant or award | +28,887 | — | 28,887 | Form 4 |
| 3 June 2026 | Varon Leslie F | Director | Grant or award | +22,822 | — | 80,364 | Form 4 |
| 3 June 2026 | Vergis Janet S. | Director | Grant or award | +22,822 | — | 67,324 | Form 4 |
| 3 June 2026 | Zurbay Donald | Director | Grant or award | +22,822 | — | 29,693 | Form 4 |
| 3 June 2026 | Lucier Gregory T | Director | Grant or award | +38,382 | — | 38,382 | Form 4 |
| 3 June 2026 | Lucier Gregory T | Director | Gift | −38,382 | — | 0 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Dentsply Sirona page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.